![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JW Regan, TJ Bailey, DJ Pepperl, KL Pierce, AM Bogardus, JE Donello, CE Fairbairn, KM Kedzie, DF Woodward and DW Gil
Department of Pharmacology and Toxicology, University of Arizona, Tucson 85721.
A cDNA that when expressed has the binding and functional characteristics of the pharmacologically defined EP2 prostaglandin (PG) receptor [Cardiovasc. Drug Rev. 11:165-179 (1993)] has been cloned from a human placenta library. This clone, known as Hup-4, encodes a protein of 358 amino acids that has only approximately 30% overall identity with other PG receptors, including mouse and human clones that have been designated as EP2 receptors [J. Biol. Chem. 268:7759-7762 (1993); Biochem. Biophys. Res. Commun. 197:263-270 (1993)]. In COS-7 cells transfected with Hup-4, PGE2 stimulated the formation of cAMP with an EC50 of approximately 50 nM. The EP2-selective agonists AH13205 and butaprost were also active, with EC50 values in the range of 2-6 microM. The order of potency of PGs for competition with binding of [3H]PGE2 to membranes prepared from COS-7 cells transfected with Hup-4 was PGE2 > or = PGE1 > 16,16-dimethyl-PGE2 > or = 11-deoxy-PGE1 > butaprost > AH13205 > 19(R)-OH-PGE2. Natural PGs and analogues that are selective for the FP (PGF2a), DP (PGD2), EP1 (sulprostone), EP3 (MB 28767), and EP4 (1-OH-PGE1) receptors were inactive or competed poorly with the binding of [3H]PGE2 (< 50% displacement of specific binding at 10 microM). Northern blot analysis showed the presence of a Hup-4 message of approximately 3.1 kilobases in mRNA from human lung and placenta. Reverse transcription-polymerase chain reaction studies also indicated that Hup-4 is probably expressed in human uterus and in HL-60 (human promyelocytic leukemia) cells. Our findings suggest that Hup-4 encodes the pharmacologically defined EP2 receptor, whereas the mouse and human cDNAs previously classified as EP2 may represent another EP receptor subtype or the recently defined EP4 subtype [Prostaglandins 47:151-168 (1994)].
This article has been cited by other articles:
|
|
 |
|
  T. Takahashi, H. Uehara, Y. Bando, and K. Izumi Soluble EP2 neutralizes prostaglandin E2-induced cell signaling and inhibits osteolytic tumor growth Mol. Cancer Ther., September 1, 2008; 7(9): 2807 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Donnini, F. Finetti, R. Solito, E. Terzuoli, A. Sacchetti, L. Morbidelli, P. Patrignani, and M. Ziche EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways FASEB J, August 1, 2007; 21(10): 2418 - 2430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Burelout, P. H. Naccache, and S. G. Bourgoin Dissociation between the translocation and the activation of Akt in fMLP-stimulated human neutrophils--effect of prostaglandin E2 J. Leukoc. Biol., June 1, 2007; 81(6): 1523 - 1534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Black Jr., A. H. Palamakumbura, M. Stan, and P. C. Trackman Tissue-specific Mechanisms for CCN2/CTGF Persistence in Fibrotic Gingiva: INTERACTIONS BETWEEN cAMP AND MAPK SIGNALING PATHWAYS, AND PROSTAGLANDIN E2-EP3 RECEPTOR MEDIATED ACTIVATION OF THE c-JUN N-TERMINAL KINASE J. Biol. Chem., May 25, 2007; 282(21): 15416 - 15429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ratcliffe, A. Walding, P. A. Shelton, A. Flaherty, and I. G. Dougall Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-{alpha} release from human alveolar macrophages Eur. Respir. J., May 1, 2007; 29(5): 986 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Huang, S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L405 - L413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhou, K. Hashimoto, K. Goleniewska, J. F. O'Neal, S. Ji, T. S. Blackwell, G. A. FitzGerald, K. M. Egan, M. W. Geraci, and R. S. Peebles Jr. Prostaglandin I2 Analogs Inhibit Proinflammatory Cytokine Production and T Cell Stimulatory Function of Dendritic Cells J. Immunol., January 15, 2007; 178(2): 702 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. E. Nilsson, E. Drecoll, E. Lutjen-Drecoll, C. B. Toris, A. H.-P. Krauss, A. Kharlamb, A. Nieves, T. Guerra, and D. F. Woodward The Prostanoid EP2 Receptor Agonist Butaprost Increases Uveoscleral Outflow in the Cynomolgus Monkey. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4042 - 4049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Grigsby, S. R. Sooranna, B. Adu-Amankwa, B. Pitzer, D. E. Brockman, M. R. Johnson, and L. Myatt Regional Expression of Prostaglandin E2 and F2alpha Receptors in Human Myometrium, Amnion, and Choriodecidua with Advancing Gestation and Labor Biol Reprod, August 1, 2006; 75(2): 297 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Chemnitz, J. Driesen, S. Classen, J. L. Riley, S. Debey, M. Beyer, A. Popov, T. Zander, and J. L. Schultze Prostaglandin E2 Impairs CD4+ T Cell Activation by Inhibition of lck: Implications in Hodgkin's Lymphoma Cancer Res., January 15, 2006; 66(2): 1114 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fujino, S. Salvi, and J. W. Regan Differential Regulation of Phosphorylation of the cAMP Response Element-Binding Protein after Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2 Mol. Pharmacol., July 1, 2005; 68(1): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Astle, S. Thornton, and D. M. Slater Identification and localization of prostaglandin E2 receptors in upper and lower segment human myometrium during pregnancy Mol. Hum. Reprod., April 1, 2005; 11(4): 279 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sugimoto, T. Nakato, A. Kita, Y. Takahashi, N. Hatae, H. Tabata, S. Tanaka, and A. Ichikawa A Cluster of Aromatic Amino Acids in the i2 Loop Plays a Key Role for Gs Coupling in Prostaglandin EP2 and EP3 Receptors J. Biol. Chem., March 19, 2004; 279(12): 11016 - 11026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Cherian, B. Cheng, S. Gu, E. Sprague, L. F. Bonewald, and J. X. Jiang Effects of Mechanical Strain on the Function of Gap Junctions in Osteocytes Are Mediated through the Prostaglandin EP2 Receptor J. Biol. Chem., October 31, 2003; 278(44): 43146 - 43156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Salcedo, X. Zhang, H. A. Young, N. Michael, K. Wasserman, W.-H. Ma, M. Martins-Green, W. J. Murphy, and J. J. Oppenheim Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells Blood, September 15, 2003; 102(6): 1966 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Arosh, S. K. Banu, P. Chapdelaine, V. Emond, J. J. Kim, L. A. MacLaren, and M. A. Fortier Molecular Cloning and Characterization of Bovine Prostaglandin E2 Receptors EP2 and EP4: Expression and Regulation in Endometrium and Myometrium during the Estrous Cycle and Early Pregnancy Endocrinology, July 1, 2003; 144(7): 3076 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Richards and R. W. Brueggemeier Prostaglandin E2 Regulates Aromatase Activity and Expression in Human Adipose Stromal Cells via Two Distinct Receptor Subtypes J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2810 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fujino, W. Xu, and J. W. Regan Prostaglandin E2 Induced Functional Expression of Early Growth Response Factor-1 by EP4, but Not EP2, Prostanoid Receptors via the Phosphatidylinositol 3-Kinase and Extracellular Signal-regulated Kinases J. Biol. Chem., March 28, 2003; 278(14): 12151 - 12156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Lemieux, S. S. Rahal, and C. R. J. Kennedy PGE2 reduces arachidonic acid release in murine podocytes: evidence for an autocrine feedback loop Am J Physiol Cell Physiol, February 1, 2003; 284(2): C302 - C309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schmitz, M.J. Leroy, E. Dallot, M. Breuiller-Fouche, F. Ferre, and D. Cabrol Interleukin-1{beta} induces glycosaminoglycan synthesis via the prostaglandin E2 pathway in cultured human cervical fibroblasts Mol. Hum. Reprod., January 1, 2003; 9(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Konger, G. A. Scott, Y. Landt, J. H. Ladenson, and A. P. Pentland Loss of the EP2 Prostaglandin E2 Receptor in Immortalized Human Keratinocytes Results in Increased Invasiveness and Decreased Paxillin Expression Am. J. Pathol., December 1, 2002; 161(6): 2065 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hosoi, Y. Koguchi, E. Sugikawa, A. Chikada, K. Ogawa, N. Tsuda, N. Suto, S. Tsunoda, T. Taniguchi, and T. Ohnuki Identification of a Novel Human Eicosanoid Receptor Coupled to Gi/o J. Biol. Chem., August 23, 2002; 277(35): 31459 - 31465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schlotzer-Schrehardt, M. Zenkel, and R. M. Nusing Expression and Localization of FP and EP Prostanoid Receptor Subtypes in Human Ocular Tissues Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1475 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al. Prostanoid receptors: ontogeny and implications in vascular physiology Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1343 - R1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kimura, S. Osumi, and M. Ogihara Prostaglandin E2 (EP1) Receptor Agonist-Induced DNA Synthesis and Proliferation in Primary Cultures of Adult Rat Hepatocytes: The Involvement of TGF-{alpha} Endocrinology, October 1, 2001; 142(10): 4428 - 4440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Moreland, H. Albadawi, C. Bratton, G. Patton, I. Goldstein, A. Traish, and M. T. Watkins O2-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H552 - H558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshida, H. Sakamoto, T. Horiuchi, S. Yamamoto, A. Suematsu, H. Oda, and Y. Koshihara Involvement of Prostaglandin E2 in Interleukin-1{{alpha}}-Induced Parathyroid Hormone-Related Peptide Production in Synovial Fibroblasts of Patients with Rheumatoid Arthritis J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3272 - 3278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Ungrin, M.-C. Carrière, D. Denis, S. Lamontagne, N. Sawyer, R. Stocco, N. Tremblay, K. M. Metters, and M. Abramovitz Key Structural Features of Prostaglandin E2 and Prostanoid Analogs Involved in Binding and Activation of the Human EP1 Prostanoid Receptor Mol. Pharmacol., June 1, 2001; 59(6): 1446 - 1456. [Abstract] [Full Text]
|
|
|
|
|
|
S. Desai, H. April, C. Nwaneshiudu, and B. Ashby Comparison of Agonist-Induced Internalization of the Human EP2 and EP4 Prostaglandin Receptors: Role of the Carboxyl Terminus in EP4 Receptor Sequestration Mol. Pharmacol., April 13, 2001; 58(6): 1279 - 1286. [Abstract] [Full Text]
|
|
|
|
|
|
T. Schmitz, E. Dallot, M.J. Leroy, M. Breuiller-Fouche, F. Ferre, and D. Cabrol EP4 receptors mediate prostaglandin E2-stimulated glycosaminoglycan synthesis in human cervical fibroblasts in culture Mol. Hum. Reprod., April 1, 2001; 7(4): 397 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C.S. Smith, W. X. Wu, and P. W. Nathanielsz Effects of Gestational Age and Labor on Expression of Prostanoid Receptor Genes in Baboon Uterus Biol Reprod, April 1, 2001; 64(4): 1131 - 1137. [Abstract] [Full Text]
|
|
|
|
|
|
S. Tavakoli, M. J. Cowan, T. Benfield, C. Logun, and J. H. Shelhamer Prostaglandin E2-induced interleukin-6 release by a human airway epithelial cell line Am J Physiol Lung Cell Mol Physiol, January 1, 2001; 280(1): L127 - L133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-L. Erkinheimo, K. Saukkonen, K. Narko, J. Jalkanen, O. Ylikorkala, and A. Ristimäki Expression of Cyclooxygenase-2 and Prostanoid Receptors by Human Myometrium J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3468 - 3475. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Hardy, I. Dumont, M. Bhattacharya, X. Hou, P. Lachapelle, D. R. Varma, and S. Chemtob Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy Cardiovasc Res, August 18, 2000; 47(3): 489 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, T. Akahoshi, S. Jiang, R. Namai, H. Kitasato, H. Endo, T. Kameya, and H. Kondo Induction of neutrophil death resembling neither apoptosis nor necrosis by ONO-AE-248, a selective agonist for PGE2 receptor subtype 3 J. Leukoc. Biol., August 1, 2000; 68(2): 187 - 193. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Enomoto, K. Ikejima, S. Yamashina, A. Enomoto, T. Nishiura, T. Nishimura, D. A. Brenner, P. Schemmer, B. U. Bradford, C. A. Rivera, et al. Kupffer cell-derived prostaglandin E2 is involved in alcohol-induced fat accumulation in rat liver Am J Physiol Gastrointest Liver Physiol, July 1, 2000; 279(1): G100 - G106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Breyer and R. M. Breyer Prostaglandin E receptors and the kidney Am J Physiol Renal Physiol, July 1, 2000; 279(1): F12 - F23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Qu, L. M. Graves, and R. G. Thurman PGE2 stimulates O2 uptake in hepatic parenchymal cells: involvement of the cAMP-dependent protein kinase Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G1048 - G1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid Receptors: Structures, Properties, and Functions Physiol Rev, October 1, 1999; 79(4): 1193 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Morris and C. C. Malbon Physiological Regulation of G Protein-Linked Signaling Physiol Rev, October 1, 1999; 79(4): 1373 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Stillman, M. D. Breyer, and R. M. Breyer Importance of the Extracellular Domain for Prostaglandin EP2 Receptor Function Mol. Pharmacol., September 1, 1999; 56(3): 545 - 551. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. MORATH, T. KLEIN, H. W. SEYBERTH, and R. M. NÜSING Immunolocalization of the Four Prostaglandin E2 Receptor Proteins EP1, EP2, EP3, and EP4 in Human Kidney J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1851 - 1860. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. BRODT-EPPLEY and L. MYATT Prostaglandin Receptors in Lower Segment Myometrium During Gestation and Labor Obstet. Gynecol., January 1, 1999; 93(1): 89 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Paternotte, D. Rudnicki, C. Fizames, C.-S. Davoine, D. Mavel, A. Dürr, D. Samson, C. Marquette, D. Muselet, N. Vega-Czarny, et al. Quality Assessment of Whole Genome Mapping Data in the Refined Familial Spastic Paraplegia Interval on Chromosome 14q Genome Res., November 1, 1998; 8(11): 1216 - 1227. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Yu and K. Chadee Prostaglandin E2 Stimulates IL-8 Gene Expression in Human Colonic Epithelial Cells by a Posttranscriptional Mechanism J. Immunol., October 1, 1998; 161(7): 3746 - 3752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Qu, Z. Zhong, G. E. Arteel, and R. G. Thurman Stimulation of oxygen uptake by prostaglandin E2 is oxygen dependent in perfused rat liver Am J Physiol Gastrointest Liver Physiol, September 1, 1998; 275(3): G542 - G549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Kedzie, J. E. Donello, H. A. Krauss, J. W. Regan, and D. W. Gil A Single Amino-Acid Substitution in the EP2 Prostaglandin Receptor Confers Responsiveness to Prostacyclin Analogs Mol. Pharmacol., September 1, 1998; 54(3): 584 - 590. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Rage, B. J. Lee, Y. J. Ma, and S. R. Ojeda Estradiol Enhances Prostaglandin E2 Receptor Gene Expression in Luteinizing Hormone-Releasing Hormone (LHRH) Neurons and Facilitates the LHRH Response to PGE2 by Activating a Glia-to-Neuron Signaling Pathway J. Neurosci., December 1, 1997; 17(23): 9145 - 9156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bastepe and B. Ashby The Long Cytoplasmic Carboxyl Terminus of the Prostaglandin E2 Receptor EP4 Subtype Is Essential for Agonist-Induced Desensitization Mol. Pharmacol., February 1, 1997; 51(2): 343 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Pierce, T. J. Bailey, P. B. Hoyer, D. W. Gil, D. F. Woodward, and J. W. Regan Cloning of a Carboxyl-terminal Isoform of the Prostanoid FP Receptor J. Biol. Chem., January 10, 1997; 272(2): 883 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Crichton, G. C.S. Smith, and G. L. Smith {alpha}-Toxin-permeabilised rabbit fetal ductus arteriosus is more sensitive to Ca2+ than aorta or main pulmonary artery Cardiovasc Res, January 1, 1997; 33(1): 223 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Okuda-Ashitaka, K. Sakamoto, T. Ezashi, K. Miwa, S. Ito, and O. Hayaishi Suppression of Prostaglandin E Receptor Signaling by the Variant Form of EP1 Subtype J. Biol. Chem., December 6, 1996; 271(49): 31255 - 31261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Arakawa, O. Laneuville, C. A. Miller, K. M. Lakkides, B. A. Wingerd, D. L. DeWitt, and W. L. Smith Prostanoid Receptors of Murine NIH 3T3 and RAW 264.7Cells. STRUCTURE AND EXPRESSION OF THE MURINE PROSTAGLANDIN EP4 RECEPTOR GENE J. Biol. Chem., November 22, 1996; 271(47): 29569 - 29575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zeng, S. An, and E. J. Goetzl Regulation of Expression of Matrix Metalloproteinase-9 in Early Human T Cells of the HSB.2 Cultured Line by the EP3 Subtype of Prostaglandin E2 Receptor J. Biol. Chem., November 1, 1996; 271(44): 27744 - 27750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Wang, H. J. Cao, V. D. Winn, L. J. Rezanka, Y. Frobert, C. H. Evans, D. Sciaky, D. A. Young, and T. J. Smith Leukoregulin Induction of Prostaglandin-Endoperoxide H Synthase-2 in Human Orbital Fibroblasts. AN IN VITRO MODEL FOR CONNECTIVE TISSUE INFLAMMATION J. Biol. Chem., September 13, 1996; 271(37): 22718 - 22728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Boie, N. Sawyer, D. M. Slipetz, K. M. Metters, and M. Abramovitz Molecular Cloning and Characterization of the Human Prostanoid DP Receptor J. Biol. Chem., August 11, 1995; 270(32): 18910 - 18916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kobayashi, F. Ushikubi, and S. Narumiya Amino Acid Residues Conferring Ligand Binding Properties of Prostaglandin I and Prostaglandin D Receptors. IDENTIFICATION BY SITE-DIRECTED MUTAGENESIS J. Biol. Chem., August 4, 2000; 275(32): 24294 - 24303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Penn, R. M. Pascual, Y.-M. Kim, S. J. Mundell, V. P. Krymskaya, R. A. Panettieri Jr., and J. L. Benovic Arrestin Specificity for G Protein-coupled Receptors in Human Airway Smooth Muscle J. Biol. Chem., August 24, 2001; 276(35): 32648 - 32656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fujino, K. A. West, and J. W. Regan Phosphorylation of Glycogen Synthase Kinase-3 and Stimulation of T-cell Factor Signaling following Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2 J. Biol. Chem., January 18, 2002; 277(4): 2614 - 2619. [Abstract] [Full Text] [PDF]
|
|
